Intraperitoneal Chemotherapy in Recurrent Ovarian Cancer
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexFemale
Age20+
SponsorFar Eastern Memorial Hospital
About this trial
This study aims to compare intravenous chemotherapy versus intraperitoneal chemotherapy in patients with recurrent ovarian cancer.
Eligibility criteria
Qualifiers
women who had recurrent ovarian cancer and was treated with either intravenous or intraperitoneal platinum based chemotherapy
Disqualifiers
women who did not complete the designated treatment course (exception to those who had to quit due to progressive disease or death of any cause)
Trial design
Treatments tested in this trial
- Chemotherapy
Treatment groups
80 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov